Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Adamas Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $66.1 million SEC-registered common stock offering of 2,875,000 shares of common stock of Adamas Pharmaceuticals, Inc…
Microsemi Agrees to Acquire PMC-Sierra
Davis Polk is advising Qatalyst Partners LP as financial adviser to PMC-Sierra, Inc. in connection with its approximately $2.5 billion acquisition by Microsemi Corporation. The merger…
Back to top